Atypical mycobacteria;Micobacterias atípicas

Actas Dermo-Sifiliograficas

Volumn 95, Issue 6, 2004, Pages 331-357

  Valdés, Fernando ^a   Cid, Ana ^a  

^a HOSPITAL DA COSTA   (Spain)

Author keywords

Atypical mycobacteria; Mycobacterium; Mycobacterium infection

Indexed keywords

ATYPICAL MYCOBACTERIUM; BACTERIAL INFECTION; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MYCOBACTERIOSIS; NOMENCLATURE; PREVALENCE; REVIEW; SKIN INFECTION;

EID: 4143143068     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(04)76833-7     Document Type: Review

References (233)

1. Penso G. Premier Colloque International sur les Mycobacteries. 1st ed. Anvers: Janssens, 1959.
2. Street ML, Umbert-Millet IJ, Roberts GD, Su WP. Nontuberculous mycobacterial infections of the skin. Report of fourteen cases and review of the literature. J Am Acad Dermatol 1991;24:208-15.
3. Ruiz Manzano J, Manterola JM, Ausina V, Sauret J. Nomenclatura y clasificación de las micobacterias. Arch Bronconeumol 1998;34:154-7.
4. a ed. Madrid: McGraw-Hill-Interamericana de España, 1998; p. 1167-72.
5. a ed. Washington DC: ASM Press, 1999; p. 399-437.
6. a ed. Washington DC: ASM Press, 1995; p. 401-37.
7. Casal M. Cómo denominar a las micobacterias diferentes a Mycobacterium tuberculosis y a M. leprae. Enferm Infecc Microbiol Clin 2003;21:296-8.
8. Casal M. Las micobacteriosis como enfermedad emergente. Enferm Infecc Microbiol Clin 2000;18:55-8.
9. Casal-Roman M. Réplica al artículo: Significado clínico del aislamiento de Mycobacterium kansasiiy valoración de la necesidad de identificación de las micobacterias no tuberculosas. Enferm Infecc Microbiol Clin 2002;20:475; author reply 475-6.
10. Kazda J. Ecology of Micobacteriae. 1st ed. London: Kluwer Academic publishers, 2000.
11. Wallace RJ Jr. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994;13:953-60.
12. Kusunoki S, Ezaki T. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol 1992;42:240-5.
13. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959;43:273-90.
14. Roberts GD, Koneman EW, Kim YK. Mycobacterium. En: Ballows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of Clinical Microbiology. 5th ed. Washington DC: ASM Press, 1991; p.304-39.
15. Woods GL, Washington JA 2nd. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987;9:275-94.
16. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003;16:319-54.
17. a ed. Madrid: Harcourt, 2000; p. 2656-60.
18. Palenque E. Skin disease and nontuberculous atypical mycobacteria. Int J Dermatol 2000;39:659-66.
19. Gruft H, Falkinham JO 3rd, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981;3:990-6.
20. Grange JM, Noble WC, Yates MD, Collins CH. Inoculation mycobacterioses. Clin Exp Dermatol 1988;13:211-20.
21. Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria. Semin Respir Infect 1996;11:244-51.
22. Medina MV, Sauret J, Caminero JA. Enfermedades producidas por micobacterias ambientales. Med Clin (Barc) 1999;113:621-30.
23. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis 2000;31:958-67.
24. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-14.
25. Kleeberg HH. Epidemiology of mycobacteria other than tubercle bacilli in South Africa. Rev Infect Dis 1981;3:1008-12.
26. Debrunner M, Salfinger M, Brandli O, Von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992;15:330-45.
27. Jenkins PA. The epidemiology of opportunist mycobacterial infections in Wales, 1952-1978. Rev Infect Dis 1981;3:1021-3.
28. Martín N, Rosselló J. Micobacterias ambientales en España: aislamientos en el periodo 1976-1996. Med Clin (Barc) 2000;115:663-70.
29. Martín N, González T, Fernández F. Micobacteriosis: presentación de 38 casos. Med Clin (Barc) 1985;84:651-4.
30. Esteban J, Gutiérrez F, Farina MC, et al. Significado clínico de los aislamientos de micobacterias de crecimiento rápido. Enferm Infecc Microbiol Clin 1997;15:260-3.
31. a ed. Córdoba: Servicio de Publicaciones de la Universidad de Córdoba, 2000.
32. Arasteh KN, Cordes C, Ewers M, et al. HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factors. Eur J Med Res 2000;5:424-30.
33. Ausina V. ¿Qué puede ofrecer actualmente el laboratorio de micobacterias en la formación profesional del microbiólogo clínico? Enferm Infecc Microbiol Clin 2003;21: 44-8.
34. Centers for Disease Control and Prevention and National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. 3rd ed. Washington: U.S. Government Printing Office, 1993.
35. Salfinger M, Pfyffer GE. The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis 1994;13:961-79.
36. Bermúdez P, Colmenero JD, López JJ, Barón MA. Infección diseminada por Mycobacterium celatum. Enferm Infecc Microbiol Clin 2001;19:349-50.
37. Uría MJ, García J, Menéndez JJ, Jiménez MS. Infección por Mycobacterium lentiflavum: a propósito de un caso y revisión de la literatura médica. Enferm Infecc Microbiol Clin 2003;21:274-5.
38. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15:716-46.
39. Sniezek PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 2003;139:629-34.
40. Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M. Laboratory diagnosis of nontuberculous mycobacteria. Clin Chest Med 2002;23:585-97.
41. Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 2001;14:704-26.
42. Chemlal K, Portaels F. Molecular diagnosis of nontuberculous mycobacteria. Curr Opin Infect Dis 2003;16:77-83.
43. Butler WR, O'Connor SP, Yakrus MA, Gross WM. Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum. J Clin Microbiol 1994;32:536-8.
44. Somoskovi A, Hotaling JE, Fitzgerald M, et al. False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay. J Clin Microbiol 2000;38:2743-5.
45. Itoh S, Kazumi Y, Abe C, Takahashi M. Heterogeneity of RNA polymerase gene (rpoB) sequences of Mycobacterium gordonae clinical isolates identified with a DNA probe kit and by conventional methods. J Clin Microbiol 2003;41:1656-63.
46. Esteban J, Molleja A, Cabria F, Jiménez MS. SDS-PAGE for identification of species belonging to the Mycobacterium fortuitum complex. Clin Microbiol Infect 2003;9:327-31.
47. Harmsen D, Rothganger J, Singer C, Albert J, Frosch M. Intuitive hypertext-based molecular identification of micro-organisms. Lancet 1999;353:291.
48. Hall GS, Parshall S. Use of the concentration gradient diffusion assay (Etest) for susceptibility testing of anaerobes, fungi, and Mycobacterium spp. Clin Microbiol Newsl 2002;24:105-9.
49. Rodríguez Díaz JC, López M, Ruiz M, Royo G. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. Int J Antimicrob Agents 2003; 21:585-8.
50. Parsad D, Pandhi R, Dogra S. A guide to selection and appropriate use of macrolides in skin infections. Am J Clin Dermatol 2003;4:389-97.
51. Brown-Elliott BA, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrob Agents Chemother 2003;47:1736-8.
52. Brown BA, Swenson JM, Wallace RJ Jr. Broth microdilution test for rapidly growing mycobacteria. En: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Vol. 11, ed. Washington DC: American Society for Microbiology Book Division, 1992; p. 5.11.1-5.11.10.
53. Inderlied CB, Nash K. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. En: Lorian V, editor. Antibiotics in laboratory medicine. 4th ed. Baltimore: Williams and Wilkins, 1996; p. 127-75.
54. Koontz FP, Erwin ME, Barrett MS, Jones RN. E-test for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates. Diagn Microbiol Infect Dis 1994;19:183-6.
55. Woods GL, Brown-Elliott BA, Desmond EP, et al. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic Actinomycetes: tentative standard. NCCLS document M24-T2. 2nd ed. Pennsylvania: NCCLS, 2000.
56. Panesar J, Higgins K, Daya H, Forte V, Allen U. Nontuberculous mycobacterial cervical adenitis: a ten-year retrospective review. Laryngoscope 2003;113:149-54.
57. Maltezou HC, Spyridis P, Kafetzis DA. Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J 1999;18:968-70.
58. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis 1992;15:1-10.
59. Whittam LR, Rao GG, Smith CH. Mycobacterium chelonae infection in a patient with chronic active hepatitis. Clin Exp Dermatol 1998;23:238-9.
60. Zahid MA, Klotz SA, Goldstein E, Bartholomew W. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin Infect Dis 1994;18:999-1001.
61. Dalovisio JR, Pankey GA. Dermatologic manifestations of nontuberculous mycobacterial diseases. Infect Dis Clin North Am 1994;8:677-88.
62. Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol 1982;13:485-95.
63. Rodríguez G, Ortegon M, Camargo D, Orozco LC. Iatrogenic Mycobacterium abscessus infection: histopathology of 71 patients. Br J Dermatol 1997;137:214-8.
64. Bartralot R, Pujol RM, García-Patos V, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol 2000;27:124-9.
65. Farhi DC, Mason UG 3rd, Horsburgh CR Jr. Pathologic findings in disseminated Mycobacterium avium-intracellulare infection. A report of 11 cases. Am J Clin Pathol 1986;85:67-72.
66. Cole GW, Gebhard J. Mycobacterium avium infection of the skin resembling lepromatous leprosy. Br J Dermatol 1979;101:71-4.
67. Califano L, Cannavo SP, Malara G. Verrucous nodule of the finger. Arch Dermatol 1998;134:365-6, 9.
68. Lucas S. Enfermedades bacterianas. En: Elder D, Elenitsas R, Jaworsky C, Johnson B, editors. Lever: Histopatología de la piel, ed. Bogotá: D'Vinni Editorial Ltda, 1997; p. 407-48.
69. Barr KL, Lowe L, Su LD. Mycobacterium marinum infection simulating interstitial granuloma annulare: a report of two cases. Am J Dermatopathol 2003;25:148-51.
70. Busam KJ, Kiehn TE, Salob SP, Myskowski PL. Histologic reactions to cutaneous infections by Mycobacterium haemophilum. Am J Surg Pathol 1999;23:1379-85.
71. Alangaden GJ, Lerner SA. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis 1997;25:1213-21.
72. a ed. Barcelona: Masson, 2002; p. 161-268.
73. Wright PW, Wallace RJ Jr. Antimycobacterial agents. En: Braunwald E, Fauci AS, Kasper DL, Hauser SL, editors. Harrison's principles of Internal Medicine. 15th ed. Madrid: McGraw-Hill, 2001; p. 1017-24.
74. Aronson J. Spontaneous tuberculosis in saltwater fish. Infect Dis 1926;39:315-20.
75. Linell F, Norden A. Mycobacterium balnei, a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand Suppl 1954;33:1-84.
76. González AF, Menéndez CL, Palacios JJ. Granuloma de los acuarios. Infección cutanea por mycobacterium marinum. Actas Dermosifiliogr 1995;86:36-7.
77. De la Torre C, Vega A, Carracedo A, Toribio J. Identification of Mycobacterium marinum in sea-urchin granulomas. Br J Dermatol 2001;145:114-6.
78. Kullavanijaya P, Sirimachan S, Bhuddhavudhikrai P. Mycobacterium marinum cutaneous infections acquired from occupations and hobbies. Int J Dermatol 1993;32:504-7.
79. López-Ávila A, Sánchez C, Montalbán C. Placa tuberosa persistente en dedo. Rev Clin Esp 1997;197:649-51.
80. Ang P, Rattana-Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 2000;39:343-7.
81. a ed. Buenos Aires: Médica Panamericana, 2001; p. 2410-29.
82. García-Latasa FJ, Paricio J, López-Pestaña MA, et al. Infección cutánea por Mycobacterium marinum de distribución esporotricoide. Actas Dermosifiliogr 1995;86:28-32.
83. Grice K. Sarcoidosis and Mycobacterium avium-intracellulare cutaneous abscesses. Clin Exp Dermatol 1983;8:323-7.
84. Hernández-Martín A, Fonseca E, González A, et al. Sporotrichoid cutaneous infection caused by Mycobacterium marinum. Pediatr Infect Dis J 1999;18:656-8.
85. Weitzul S, Eichhorn PJ, Pandya AG. Nontuberculous mycobacterial infections of the skin. Dermatol Clin 2000;18:359-77, xi-xii.
86. Clark RB, Spector H, Friedman DM, et al. Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman. J Clin Microbiol 1990;28:2570-2.
87. Collins RJ, Chow SP, Ip FK, Leung YK. Synovial involvement by Mycobacterium marinum. A histopathological study of 25 culture-proven cases. Pathology 1988;20:340-5.
88. Vázquez JA, Sobel JD. A case of disseminated Mycobacterium marinum infection in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1992;11:908-11.
89. Tchornobay AM, Claudy AL, Perrot JL, Levigne V, Denis M. Fatal disseminated Mycobacterium marinum infection. Int J Dermatol 1992;31:286-7.
90. Parent LJ, Salam MM, Appelbaum PC, Dossett JH. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis 1995;21:1325-7.
91. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994;154:1359-64.
92. Gilbert DN, Moellering RC Jr, Sande ME. The Sanford guide to antimicrobial therapy 2003. 33rd ed. EE.UU.: Sanford, 2003.
93. Sande ME, Gilbert DN, Moellering RC, Jr. The Sanford guide to HIV/AIDS therapy 2002. 11th ed. EE.UU.: Sanford, 2002.
94. Laing RB, Wynn RF, Leen CL. New antimicrobials against Mycobacterium marinum infection. Br J Dermatol 1994;131:914.
95. Giménez R, Sánchez S, Iban RM, Ruiz M. Fish tank granuloma: response to treatment with clarithromycin. JEADV 1999;12:81-2.
96. Gawkrodger DJ. Mycobacterial infections. En: Rook A, Wilkinson DS, Ebling FJG, editors. Textbook of Dermatology. 6th ed. Oxford: Blackwell Scientific Publ, 1998; p. 1181-214.
97. Grange JM. Mycobacterium chelonae. Tubercle 1981;62:273-6.
98. Johnson S, Weir TW. Multiple cutaneous ulcers of the legs. Mycobacterium chelonae infection. Arch Dermatol 1993;129:1190-1, 93.
99. Kubica GP, Baess I, Gordon RE, et al. A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol 1972;73:55-70.
100. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992;166:405-12.
101. McWhinney PH, Yates M, Prentice HG, et al. Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clin Infect Dis 1992;14:1208-12.
102. Chastain MA, Buckley J, Russo GG. Mycobacterium chelonae/abscessus complex infection in a liver transplant patient. Int J Dermatol 2001;40:769-74.
103. Choonhakarn C, Chetchotisakd P, Jirarattanapochai K, Mootsikapun P. Sweet's syndrome associated with non-tuberculous mycobacterial infection: a report of five cases. Br J Dermatol 1998;139:107-10.
104. Bañuls J, Ramón R, Pascual E, et al. Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis. Br J Dermatol 2000;143:1345.
105. Hevia C, Bajo MA, Sánchez-Tomero JA, et al. Peritoneal catheter exit-site infections caused by rapidly-growing atypical mycobacteria. Nephrol Dial Transplant 2000;15: 1458-60.
106. Burns JL, Malhotra U, Lingappa J, Smith S. Unusual presentations of nontuberculous mycobacterial infections in children. Pediatr Infect Dis J 1997;16:802-6.
107. Mauriello JA Jr. Atypical mycobacterial infection of the periocular region after periocular and facial surgery. Ophthal Plast Reconstr Surg 2003;19:182-8.
108. Alvarenga L, Freitas D, Hofling-Lima AL, et al. Infectious post-LASIK crystalline keratopathy caused by nontuberculous mycobacteria. Cornea 2002;21:426-9.
109. Meyers H, Brown-Elliott BA, Moore D, et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 2002;34:1500-7.
110. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317:197-201.
111. Herrero JB, Borbujo C, Román MT, et al. Infección cutánea por Mycobacterium chelonae. Presentación de tres casos con lesiones múltiples. Rev Clin Esp 1996;196:606-9.
112. Valencia IC, Weiss E, Sukenik E, Kerdel FA. Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. Int J Dermatol 1999;38:770-3.
113. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonae. Infect Control 1983;4:25-8.
114. Jackson PG, Keen H, Noble CJ, Simmons NA. Injection abscesses due to Mycobacterium chelonae occurring in a diabetic patient. Tubercle 1981;62:277-9.
115. Nye K, Chadha DK, Hodgkin P, et al. Mycobacterium chelonae isolation from broncho-alveolar lavage fluid and its practical implications. J Hosp Infect 1990;16:257-61.
116. Fraser VJ, Jones M, Murray PR, et al. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis 1992;145:853-5.
117. Franck N, Cabie A, Villette B, et al. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 1993;28:1019-21.
118. Pedersen A, Reibel J. Intraoral infection with Mycobacterium chelonae. A case report. Oral Surg Oral Med Oral Pathol 1989;67:262-5.
119. Nathan DL, Singh S, Kestenbaum TM, Casparian JM. Cutaneous Mycobacterium chelonae in a liver transplant patient. J Am Acad Dermatol 2000;43:333-6.
120. Drabick JJ, Duffy PE, Samlaska CP, Scherbenske JM. Disseminated Mycobacterium chelonae subspecies chelonae infection with cutaneous and osseous manifestations. Arch Dermatol 1990;126:1064-7.
121. Galil K, Thurer R, Glatter K, Barlam T. Disseminated Mycobacterium chelonae infection resulting in endocarditis. Clin Infect Dis 1996;23:1322-3.
122. Carlini ME, White AC Jr, Atmar RL. Thyroid abscess caused by Mycobacterium chelonae. Clin Infect Dis 1999;28:1183-4.
123. Eichmann A, Huszar A, Bon A. Mycobacterium chelonae infection of lymph nodes in an HIV-infected patient. Dermatology 1993;187:299-300.
124. Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.
125. Malecha MA, Doughman DJ. Mycobacterium chelonae keratitis associated with soft contact lens wear. Clao J 2002;28:228-30.
126. Avery RK, Eavey RD, Della Torre T, Ramos D, Pasternack MS. Bilateral otitis media and mastoiditis caused by a highly resistant strain of Mycobacterium chelonae. Pediatr Infect Dis J 1996;15:1037-40.
127. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med 1988;319:978-82.
128. Martín JC, Sancho T, Sierra FJ, et al. Mycobacterium chelonae infection mimicking cutaneous vasculitis: case report. Clin Infect Dis 1996;23:1189-91.
129. García-Río I, Fernández-Peñas P, Fernández-Herrera J, García-Díez A. Infección cutánea por Mycobacterium chelonae. Revisión de seis casos. Actas Dermosifiliogr 2002;93: 584-7.
130. Swetter SM, Kindel SE, Smoller BR. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol 1993;28:352-5.
131. Ryan ME, Ferrigno K, O'Boyle T, Long SS. Periodic fever and skin lesions caused by disseminated Mycobacterium chelonae infection in an immunocompetent child. Pediatr Infect Dis J 1996;15:270-2.
132. Brady RC, Strife CF, Sheth AP, Passo M, Schleiss MR. An adolescent with nephrotic syndrome and multiple leg nodules. Pediatr Infect Dis J 1998;17:1057-8, 61-3.
133. Bordet AL, Machet L, De Muret A, et al. Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin. Ann Dermatol Venereol 1997;124:251-3.
134. Suryanarayan K, Campbell J, Eskenazi AE. Nontuberculous mycobacterial infections in pediatric acute leukemia. J Pediatr Hematol Oncol 2002;24:558-60.
135. Gart GS, Forstall GJ, Tomecki KJ. Mycobacterial skin disease: approaches to therapy. Semin Dermatol 1993;12:352-6.
136. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-6.
137. Driscoll MS, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 1997;36:495-6.
138. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995;20:443-4.
139. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-71.
140. Kelley LC, Deering KC, Kaye ET. Cutaneous Mycobacterium chelonae presenting in an immunocompetent host: case report and review of the literature. Cutis 1995;56:293-5.
141. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J Syst Bacteriol 1978;28:67-75.
142. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001;33:330-7.
143. Geisler WM, Harrington RD, Wallis CK, Harnisch JP, Liles WC. Broad spectrum of dermatologic manifestations caused by Mycobacterium haemophilum infection. Arch Dermatol 2002;138:229-30.
144. Stimmler MM. Infectious arthritis. Kelly's textbook of internal medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000. Disponible en: http://gateway.ovid.com/
145. Friedli A, Krischer J, Hirschel B, Saurat JH, Pechere M. An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDS. J Am Acad Dermatol 2000;43:913-5.
146. Shih JY, Hsueh PR, Chang YL, et al. Pyomyositis due to Mycobacterium haemaphilum in a patient with polymyositis and long-term steroid use. Clin Infect Dis 1998;26:505-7.
147. Badalik L, Svejnochova M, Honzatkova Z, Kristufek P. Epidemiologic and microbiologic aspects of mycobacteriosis in Slovakia. M. fortuitum. Bratisl Lek Listy 1997;98:559-62.
148. Kullavanijaya P. Atypical mycobacterial cutaneous infection. Clin Dermatol 1999;17:153-8; discussion 05-6.
149. Choueiry MA, Scurto PL, Flynn PM, Rao BN, Hughes WT. Disseminated infection due to Mycobacterium fortuitum in a patient with desmoid tumor. Clin Infect Dis 1998;26:237-8.
150. Rodgers GL, Mortensen JE, Blecker-Shelly D, Fisher MC, Long SS. Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous Mycobacterium species. Pediatr Infect Dis J 1996;15:260-4.
151. Murillo J, Torres J, Bofill L, et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol 2000;136:1347-52.
152. Retief CR, Tharp MD. Mycobacterium fortuitum panniculitis in a steroid-dependent asthmatic patient. J Am Acad Dermatol 1998;39:650-3.
153. O'Brien DP, Rawluk DJ. Iatrogenic Mycobacterium infection after an epidural injection. Spine 1999;24:1257-9.
154. Kuritsky JN, Bullen MG, Broome CV, et al. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938-9.
155. Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;159:708-16.
156. Butt AA. Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. Am J Med Sci 1998;315:50-5.
157. Nolan CM, Hashisaki PA, Dundas DF. An outbreak of soft-tissue infections due to Mycobacterium fortuitum associated with electromyography. J Infect Dis 1991;163:1150-3.
158. Wallace RJ Jr, Steele LC, Labidi A, Silcox VA. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J Infect Dis 1989;160:281-8.
159. Haiavy J, Tobin H. Mycobacterium fortuitum infection in prosthetic breast implants. Plast Reconstr Surg 2002;109:2124-8.
160. Mukhopadhya A, Samal SC, Mukundan U, et al. Perianal fistulae caused by Mycobactenum fortuitum. J Clin Gastroenterol 2003;36:147-8.
161. Cooke FJ, Friedland JS. Spontaneous breast abscess due to Mycobacterium fortuitum. Clin Infect Dis 1998;26:760-1.
162. Passeron T, Desruelles F, Fosse T, et al. Disseminated papulopustular eruption due to Mycobacterium fortuitum in an immunocompetent patient. Clin Infect Dis 1999;28:924-5.
163. Sack JB. Disseminated infection due to Mycobacterium fortuitum in a patient with AIDS. Rev Infect Dis 1990;12:961-3.
164. Nahabedian SE, Togneri AM, Caloia HF, Cimalando LE. [Infection of the wrist by Mycobacterium fortuitum]. Enferm Infecc Microbiol Clin 1998;16:149-50.
165. Graham JC, Tweddle DA, Jenkins DR, Pollitt C, Pedler SJ. Non-tuberculous mycobacterial infection in children with cancer. Eur J Clin Microbiol Infect Dis 1998;17:394-7.
166. Swanson DS. Central venous catheter-related infections due to nontuberculous Mycobacterium species. Pediatr Infect Dis J 1998;17:11634.
167. Kirschner RA Jr, Parker BC, Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis 1992;145:271-5.
168. Cox SK, Strausbaugh LJ. Chronic cutaneous infection caused by Mycobacterium intracellulare. Arch Dermatol 1981;117:794-6.
169. Maurice PD, Bunker C, Giles F, Goldstone A, Holton J. Mycobacterium avium-intracellulare infection associated with hairy-cell leukemia. Arch Dermatol 1988;124:1545-9.
170. Del Giudice P, Durant J, Counillon E, et al. Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol 1999;135:1129-30.
171. Moreno S, Berenguer J. Enfermedad por Mycobacterium avium complex (MAC) en pacientes infectados por VIH. Recomendaciones del Consejo Asesor Clínico del Plan Nacional sobre el SIDA 1999;13:1-16.
172. Ichiki Y, Hirose M, Akiyama T, Esaki C, Kitajima Y. Skin infection caused by Mycobacterium avium. Br J Dermatol 1997;136:260-3.
173. Preheim LC. Other mycobacterioses. En: Benenett JC, Plum F, editors. Cecil textbook of medicine. 20th ed. Philadelphia: WB Saunders, 1996; p. 1690-91.
174. Kimerling ME, Dunlap NE. Tuberculosis and other mycobacterial diseases. En: Conn HF, editor. Conn's current therapy. 1st ed. Philadelphia: WB Saunders, 1999; p. 239-45.
175. Epps RE, el-Azhary RA, Hellinger WC, Winkelmann RK, Van Scoy RE. Disseminated cutaneous Mycobacterium avium-intracellulare resembling sarcoidosis. J Am Acad Dermatol 1995;33:528-31.
176. Komatsu H, Terunuma A, Tabata N, Tagami H. Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. Br J Dermatol 1999;141:554-7.
177. Sugita Y, Ishii N, Katsuno M, Yamada R, Nakajima H. Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system. Br J Dermatol 2000;142:789-93.
178. Martínez E, Menéndez R, Santos M, Lorente R, Marco V. Enfermedad pulmonar por micobacterias ambientales oportunistas en pacientes sin infección por el virus de la inmunodeficiencia humana. Factores de riesgo, clínica, diagnóstico y evolución. Arch Bronconeumol 1996;32: 170-5.
179. MacCallum P, Tolhurst JC, Buckle G, Sissons HA. New mycobacterial infection in man: clinical aspects. J Pathol Bacteriol 1948;60:93-102.
180. Journeau P, Fitoussi F, Jehanno P, Padovani JP, Pennecot GF. Buruli's ulcer: three cases diagnosed and treated in France. J Pediatr Orthop B 2003;12:229-32.
181. Dawson JF, Allen GE. Ulcer due to Mycobacterium ulcerans in Northern Ireland. Clin Exp Dermatol 1985;10:572-7.
182. Johnson RC, Ifebe I, Hans-Moevi A, et al. Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study. AIDS 2002;16:1704-5.
183. Jackson PG, Keen H, Noble CJ, Simmons NA. Injection abscesses in a diabetic due to Mycobacterium chelonae var abscessus. BMJ 1980;281:1105-6.
184. Inman PM, Beck A, Brown AE, Stanford JL. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969;100:141-7.
185. Zaballos P, Ara M, Carapeto FJ. Infección cutánea por Mycobacterium chelonae y M. abscessus. Piel 2001;16:379-87.
186. De Juan F, Marín MC, Bouthelier M, et al. Infección por micobacterias no tuberculosas en inmunocompetentes. An Esp Pediatr 2002;56:357-9.
187. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995;20:954-63.
188. Starke JR. Management of nontuberculous mycobacterial cervical adenitis. Pediatr Infect DisJ 2000;19:674-5.
189. Rahal A, Abela A, Arcand PH, et al. Nontuberculous mycobacterial adenitis of the head and neck in children: experience from a tertiary care pediatric center. Laryngoscope 2001;111:1791-6.
190. Kandyil R, Maloney D, Tarrand J, Duvic M. Red nodule on the finger of an immunosuppressed woman. Arch Dermatol 2002;138:689-94.
191. Ishi N, Sugita Y, Sato I, Nakajima H. A case of mycobacterial skin disease caused by Mycobacterium peregrinum and M. scrofulaceum. Acta Derm Venereol 1998;78:76-7.
192. Murray-Leisure KA, Egan N, Weitekamp MR. Skin lesions caused by Mycobacterium scrofulaceum. Arch Dermatol 1987;123:369-70.
193. Sowers WF. Swimming pool granuloma due to Mycobacterium scrofulaceum. Arch Dermatol 1972;105:760-1.
194. Phoa LL, Khong KS, Thamboo TP, Lam KN. A case of Mycobacterium scrofulaceum osteomyelitis of the right wrist. Ann Acad Med Singapore 2000;29:678-81.
195. Knuf M, Habermehl P, Zepp F, et al. Lymphadenitis colli due to non-tuberculous mycobacteria (NTM): a case-series and review of the literature. Klin Pediatr 2003;215:9-15.
196. Buhler VB, Pollak A. Human infection with atypical acid-fast organisms; report of two cases with pathologic findings. Am J Clin Pathol 1953;23:363-74.
197. Tzen CY, Chen TL, Wu TY, Yong DI, Lee HC. Disseminated cutaneous infection with Mycobacterium kansasii: genotyping versus phenotyping. J Am Acad Dermatol 2001;45:620-4.
198. Czelusta A, Moore AY. Cutaneous Mycobacterium kansasii infection in a patient with systemic lupus erythematosus: case report and review. J Am Acad Dermatol 1999;40:359-63.
199. Chaves A, Torrelo A, Mediero IG, et al. Primary cutaneous Mycobacterium kansasii infection in a child. Pediatr Dermatol 2001;18:131-4.
200. Callahan EF, Licata AL, Madison JF. Cutaneous Mycobacterium kansasii infection associated with a papulonecrotic tuberculid reaction. J Am Acad Dermatol 1997;36:497-9.
201. Paull DE, Decker GR, Brown RL. Mycobacterium kansasii empyema in a renal transplant recipient case report and review of the literature. Transplantation 2003;76:270-1.
202. Gobels K, Best J, Oette M, et al. Ocular infection caused by Mycobacterium kansasii in an AIDS patient. AIDS 2002;16:2501-2.
203. Stengem J, Grande KK, Hsu S. Localized primary cutaneous Mycobacterium kansasii infection in an immunocompromised patient. J Am Acad Dermatol 1999;41:854-6.
204. Patel S, Wolf T. Cavitary lung lesions due to coinfection of Rhodococcus equi and Mycobacterium kansasii in a patient with acquired immunodeficiency syndrome. Am J Med 2002;112:678-80.
205. Bolivar R, Satterwhite TK, Floyd M. Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol 1980;116:207-8.
206. Hirsh FS, Saffold OE. Mycobacterium kansasii infection with dermatologic manifestations. Arch Dermatol 1976;112:706-8.
207. Owens DW, McBride ME. Sporotrichoid cutaneous infection with Mycobacterium kansasii. Arch Dermatol 1969;100:54-8.
208. Marks J, Jenkins PA, Tsukamura M. Mycobacterium szulgai - a new pathogen. Tubercle 1972;53:210-4.
209. Cross GM, Guill MA, Aton JK. Cutaneous Mycobacterium szulgai infection. Arch Dermatol 1985;121:247-9.
210. Shimizu T, Kodama K, Kobayashi H, et al. Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai. Br J Dermatol 2000;142:838-40.
211. Hotta M, Minami Y, Itoda I, Yoshimori K, Takano K. A young female patient with anorexia nervosa complicated by Mycobacterium szulgai pulmonary infection. Int J Eat Disord 2004;35:115-9.
212. Merlet C, Aberrane S, Chilot F, Laroche JM. Carpal tunnel syndrome complicating hand flexor tenosynovitis due to Mycobacterium szulgai. Joint Bone Spine 2000;67:247-8.
213. Horusitzky A, Puechal X, Dumont D, et al. Carpal tunnel syndrome caused by Mycobacterium szulgai. J Rheumatol 2000;27:1299-302.
214. Luque AE, Kaminski D, Reichman R, Hardy D. Mycobacterium szulgai osteomyelitis in an AIDS patient. Scand J Infect Dis 1998;30:88-91.
215. Hurr H, Sorg T. Mycobacterium szulgai osteomyelitis. J Infect 1998;37:191-2.
216. Holmes GP, Bond GB, Fader RC, Fulcher SF. A Cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 2002;34:1039-46.
217. Frueh BE, Dubuis O, Imesch P, Bohnke M, Bodmer T. Mycobacterium szulgai keratitis. Arch Ophthalmol 2000;118:1123-4.
218. Fulcher SF, Fader RC, Rosa RH Jr. Holmes GP. Delayed-onset mycobacterial keratitis after LASIK. Cornea 2002;21:546-54.
219. Kobashi Y, Okimoto N, Soejima R. A case of pulmonary infectious disease due to Mycobacterium szulgai. Kekkaku 1999;74:715-9.
220. Tsuji T, Matsumoto H, Nakanishi K, et al. Two cases of pulmonary disease due to Mycobacterium szulgai. Kekkaku 1998;73:633-7.
221. Iwanaga T, Kishikawa R, Ikeda T, et al. Clinicopathological study of cases with Mycobacterium szulgai infectio. Kekkaku 1998;73:579-84.
222. Fang CT, Chang SC, Luh KT, et al. Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol. J Infect 1999;38:195-7.
223. Weinberger M, Berg SL, Feuerstein IM, Pizzo PA, Witebsky FG. Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature. Clin Infect Dis 1992;14:1229-39.
224. Eckburg PB, Buadu EO, Stark P, et al. Clinical and chest radiographic findings among persons with sputum culture positive for Mycobacterium gordonae: a review of 19 cases. Chest 2000;117:96-102.
225. Tokars JI, McNeil MM, Tablan OC, et al. Mycobacterium gordonae pseudoinfection associated with a contaminated antimicrobial solution. J Clin Microbiol 1990;28:2765-9.
226. Lalande V, Barbut F, Varnerot A, et al. Pseudo-outbreak of Mycobacterium gordonae associated with water from refrigerated fountains. J Hosp Infect 2001;48:76-9.
227. Zala L, Hunziker T, Braathen LR. Chronic cutaneous infection caused by Mycobacterium gordonae. Dermatology 1993;187:301-2.
228. Gengoux P, Portaels F, Lachapelle JM, et al. Skin granulomas due to Mycobacterium gordonae. Int J Dermatol 1987;26:181-4.
229. Li XJ, Wu QX, Zeng XS. Nontuberculous mycobacterial cutaneous infection confirmed by biochemical tests, polymerase chain reaction-restriction fragment length polymorphism analysis and sequencing of hsp65 gene. Br J Dermatol 2003;149:642-6.
230. London RD, Damsker B, Neibart EP, Knorr B, Bottone EJ. Mycobacterium gardonae: an unusual peritoneal pathogen in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med 1988;85:703-4.
231. Lohr DC, Goeken JA, Doty DB, Donta ST. Mycobacterium gardonae infection of a prosthetic aortic valve. JAMA 1978;239:1528-30.
232. Garofalo R, Chadwick EG, Yogev R. Mycobacterium gordonae bacteremia in an asymptomatic adolescent with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2003;22:569-70.
233. Neuman HB, Andreoni KA, Johnson MW, Fair JH, Gerber DA. Terminal ileitis secondary to Mycobacterium gordonae in a renal transplant. Transplantation 2003;75:574-5.